Citigroup
ZYME icon

Citigroup’s Zymeworks ZYME Stock Holding History

Citigroup’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.86M Buy
114,327
+3,120
+3% +$73.8K ﹤0.01% 2418
2025
Q4 		$2.93M Sell
111,207
-6,597
-6% -$144K ﹤0.01% 2404
2025
Q3 		$2.01M Sell
117,804
-38,194
-24% -$547K ﹤0.01% 2672
2025
Q2 		$1.96M Buy
155,998
+114,800
+279% +$1.37M ﹤0.01% 2667
2025
Q1 		$491K Sell
41,198
-41,938
-50% -$572K ﹤0.01% 3694
2024
Q4 		$1.22M Buy
83,136
+3,246
+4% +$45.4K ﹤0.01% 3209
2024
Q3 		$1M Buy
79,890
+25,179
+46% +$274K ﹤0.01% 3263
2024
Q2 		$466K Buy
54,711
+33,998
+164% +$303K ﹤0.01% 3440
2024
Q1 		$218K Sell
20,713
-5,256
-20% -$58.4K ﹤0.01% 3980
2023
Q4 		$270K Sell
25,969
-34,038
-57% -$271K ﹤0.01% 3788
2023
Q3 		$380K Sell
60,007
-26,012
-30% -$192K ﹤0.01% 3273
2023
Q2 		$743K Buy
86,019
+10,568
+14% +$94.6K ﹤0.01% 3061
2023
Q1 		$682K Buy
75,451
+49,593
+192% +$432K ﹤0.01% 2878
2022
Q4 		$203K Buy
25,858
+25,810
+53,771% +$181K ﹤0.01% 3714
2022
Q3 		$0 Sell
48
-565
-92% -$3.41K ﹤0.01% 6391
2022
Q2 		$3K Sell
613
-862
-58% -$5.21K ﹤0.01% 5809
2022
Q1 		$10K Buy
1,475
+665
+82% +$5.93K ﹤0.01% 5553
2021
Q4 		$13K Buy
810
+78
+11% +$1.63K ﹤0.01% 5516
2021
Q3 		$22K Sell
732
-1,172
-62% -$39K ﹤0.01% 5207
2021
Q2 		$66K Sell
1,904
-1,936
-50% -$61.4K ﹤0.01% 4682
2021
Q1 		$121K Sell
3,840
-1,026
-21% -$41.7K ﹤0.01% 4274
2020
Q4 		$230K Buy
4,866
+208
+4% +$9.66K ﹤0.01% 4880
2020
Q3 		$217K Sell
4,658
-5,538
-54% -$190K ﹤0.01% 4555
2020
Q2 		$367K Buy
10,196
+6,143
+152% +$226K ﹤0.01% 4538
2020
Q1 		$143K Buy
4,053
+2,318
+134% +$94.9K ﹤0.01% 5031
2019
Q4 		$79K Buy
+1,735
New +$63K ﹤0.01% 5963

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Citigroup's ZYME Position: Q1 2026 in Review

Citigroup increased its Zymeworks (ZYME) stake by 2.8% in Q1 2026, buying an estimated $73.8K and bringing the position to 114,327 shares worth $2.86M. The position accounts for ﹤0.01% of the portfolio, ranked #2418.

Citigroup first reported a position in ZYME in Q4 2019 and has held it in 26 quarters since. The position peaked at $2.93M in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Citigroup held 114,327 shares of Zymeworks worth $2.86M as of Q1 2026.
  • Citigroup bought 3,120 Zymeworks shares in Q1 2026, an estimated $73.8K.
  • Zymeworks made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #2418 holding.
  • Citigroup first reported a position in Zymeworks in Q4 2019 and has held it in 26 quarters since.
  • Citigroup's Zymeworks position peaked at $2.93M in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.